News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Wright Medical Group, Inc. (WGMI) Receives Department of Defense Funding for Clinical Study of OSTEOSET(R) T Bone Graft Substitute in Combat-Related Open Fracture Wounds



10/5/2010 11:32:50 AM

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced it has been awarded a $2.4 million grant from the United States Department of Defense to fund a clinical study of OSTEOSET® T bone graft substitute pellets in combat-related open fracture wounds.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES